Cerus Endovascular Receives CE Mark Approvals for its Neqstent(TM) Coil Assisted Flow Diverter Designed to Treat Intracranial Aneurysms

Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020 FREMONT, Calif. and OXFORD, United Kingdom, April 22, 2020 -- (Healthcare Sales & Marketing Network) -- Cerus Endovascular Ltd., a privately-held, commercial stage m... Devices, Neurology, Interventional, Regulatory Cerus Endovascular, Neqstent, Coil Assisted Flow Diverter, aneurysm

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2045939

Source: HSMN NewsFeed - April 22, 2020 Category: Pharmaceuticals Source Type: news